Back:  · Company News

New Medical Material for Bone Repair | High‑Purity α‑Tricalcium Phosphate

Time: 2026-09-07 Source: :

       Bone defect repair and bone tissue regeneration have long been key areas of focus in orthopedics, dentistry and regenerative medicine. Traditional bone repair materials still face significant challenges in terms of degradation rate, osteointegration and osteogenic performance.

       Leader Med‑Biotech has been dedicated to the development of medical‑grade raw materials for bioceramics, with a particular focus on the research, development, and supply of high‑purity α‑tricalcium phosphate (α‑TCP). Featuring outstanding material purity, excellent bioactivity and promising potential for osteogenic application, our α‑TCP provides high‑quality foundational material support for medical device innovation, bone repair product development, and regenerative medicine research.

α‑Tricalcium Phosphate powder

       I. Three key Advantages to meet the Full Spectrum of Clinical Needs

       ✅ Excellent Biocompatibility and Osteoconductivity

       No immune rejection and excellent osteoconductive activity, enabling firm osseous integration with host bone tissues.

       ✅ Hydration‑Setting and Biodegradability

       Upon contact with body fluid, this material undergoes a hydration reaction to sets in‑situ. It gradually degrades in‑vivo and releases Ca²⁺ and PO₄³⁻ ions, continuously supplying essential mineral elements for new‑bone formation.

       ✅ Good Flowability and Moldability

       After mixing with a liquid to form a paste, the powder exhibits excellent flowability and moldability, enabling precise filling of irregular bone defects. The high‑purity raw material system helps ensure a uniform structure of the set product and reduces the risk of impurities contributing to inflammation or localized degradation imbalance.

       Phase Analysis (XRD)

XRD pattern of α‑Tricalcium Phosphate

       No Amorphous Phase Observed.
       No characteristic peaks of other calcium phosphate phases or crystalline phases are observed.
       The XRD pattern matches ICDD PDF Card No. 09‑0348.

Product Name α‑Tricalcium Phosphate (α‑TCP)
Shelf Life 3 years
Storage Instructions Store packages in a dark, dry, well‑ventilated warehouse free of corrosive gas. Do not store together with toxic, harmful, odorous or other contaminating substances.

       III. Four Core Application Areas, Covering Medical Device and Research Applications

       1. Orthopedic Implantable Devices

       Calcium‑phosphate bioceramics, composite bone‑defect repair materials, self‑setting calcium‑phosphate bone cement, and substrate for 3D‑printed artificial bone. Applicable for clinical scenarios including traumatic bone defects, periarticular bone augmentation and spinal bone‑graft filling.

       2. Oral and Maxillofacial Implantable Devices

       Minimally‑invasive alveolar bone augmentation filling, setting‑based repair for root‑tip defects, injectable repairing materials for small maxillofacial bone defects. Suited for dental implantation, apical surgery and minimally‑invasive maxillofacial repair. Easy shaping to fit confined oral defect cavities.

       3. Regenerative Medicine & Delivery Systems

       Suitable for the development of settable tissue‑engineered scaffolds, growth factor/drug sustained‑release carriers, and rapid mineralization and regeneration materials, supporting the development of composite soft tissue–bone regeneration systems and cell‑loaded repair platforms.

       4. Biomaterial Research & Development

       Development of self‑setting calcium‑phosphate formulations, mineralization‑property comparison tests, modification research for novel minimally‑invasive medical materials. High‑purity reference raw material of choice for fundamental laboratory research and innovation projects in universities, institutes and enterprises.

       About Leader Med‑Biotech

       Wuhan Leader Med‑Biotechnology Co., Ltd., together with its affiliated Hong Kong leader Biomaterials Co., Ltd., operates a manufacturing facility in High‑Tech Park, Wuhan East‑Lake High‑Tech Development Zone. Its Hong Kong R&D division future supports material modification and the supply of medical‑grade raw materials for overseas medical device applications.

       We operate a complete production line for high‑purity α‑TCP, complying strictly with quality‑control standards for medical raw materials. Stable bulk‑supply, custom powder specifications and material‑testing technical support are available. We welcome cooperation with medical‑device manufacturers, universities, research institutes and new‑material R&D teams.

       For raw‑material customization, sample request, technical‑parameter alignment and medical‑device formulation R&D support, industry partners are welcome to contact us for potential cooperation, and jointly explore the new track of bone‑regeneration biomaterials!

α‑TCP product poster